Enanta drug to get hepatitis C priority review

June 14, 2014 4:36 AM

33 0

Enanta drug to get hepatitis C priority review

Enanta drug is all set to get hepatitis C priority review. Research based pharmaceuticals company AbbVie Inc. has reported that the US authorities have granted it permission for experimental all-oral test on the hepatitis C patients.

The Food and Drug Administration has given this permission to the company to carry out experimental regimen on the people infected with common genotype Hepatitis C virus.

Read more

To category page

Loading...